Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ana I. Velazquez Manana"'
Autor:
Meera Vimala Ragavan, Vanessa Elaine Kennedy, Rahul Banerjee, Amy M. Lin, Ana I. Velazquez Manana
Publikováno v:
Journal of Clinical Oncology. 40:190-190
190 Background: Infertility is a significant long-term consequence of cancer treatment and can negatively impact health related quality of life. As the incidence of cancer rises in younger populations and an increasing number of patients are prescrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52a106fba9f9a64b33074c6c667ceb7d
https://doi.org/10.1200/jco.2022.40.28_suppl.190
https://doi.org/10.1200/jco.2022.40.28_suppl.190
Publikováno v:
Journal of Clinical Oncology. 40:137-137
137 Background: Social risks are adverse conditions that may serve as barriers to health care and lead to poor health outcomes. Among individuals with cancer, social risks like financial hardship have been associated with delayed treatment and increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6849b0207beb08b01c81aea82d604b9
https://doi.org/10.1200/jco.2022.40.28_suppl.137
https://doi.org/10.1200/jco.2022.40.28_suppl.137
Autor:
Dame Idossa, Ana I. Velazquez Manana, Miki Horiguchi, Julia Alberth, Inas Abuali, Demetria Joy Smith-Graziani, Gilberto Lopes, Sam Joseph Lubner, Narjust Duma
Publikováno v:
Journal of Clinical Oncology. 40:11047-11047
11047 Background: Physician workforce diversity can be a driver of institutional excellence, improving innovation and reducing health disparities. The current diversity of the hematology/oncology (HO) workforce does not reflect that of the US populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a351ed7129ed7dc001eac276190f199
https://doi.org/10.1200/jco.2022.40.16_suppl.11047
https://doi.org/10.1200/jco.2022.40.16_suppl.11047
Autor:
Niharika Dixit, Ana I. Velazquez Manana, Kelly Gordon, Ivan C. Leung, Terence W. Friedlander, Miya Frick, Evelin Trejo, Kendall Levine, Rebecca Jane DeBoer, Robin Lee, Judy M. Cheng, Paul Couey, Chia-Ching Jackie Wang, Galen Joseph
Publikováno v:
Journal of Clinical Oncology. 40:e18565-e18565
e18565 Background: Diagnosis of hereditary cancers by genetic testing (GT) has significant implications for treatment decisions for individuals and risk reduction among family members. Recent guidelines have expanded the eligibility criteria for GT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::012cb796163cf0fb72304f5aed187ca9
https://doi.org/10.1200/jco.2022.40.16_suppl.e18565
https://doi.org/10.1200/jco.2022.40.16_suppl.e18565
Autor:
Ana I. Velazquez Manana, Hala Borno, Evelin Trejo, Sylvia Zhang, Abigail A. Rodriguez Saldana, Ivan C. Leung, Hilary K. Seligman, Tracy Kuo Lin
Publikováno v:
Journal of Clinical Oncology. 40:e18550-e18550
e18550 Background: Patients with cancer, especially minority and low-income individuals, are at increased risk of financial toxicity and food insecurity. The COVID-19 pandemic has added dire economic challenges to vulnerable populations leading to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df250a015293b85b7aa27d2f888b52b1
https://doi.org/10.1200/jco.2022.40.16_suppl.e18550
https://doi.org/10.1200/jco.2022.40.16_suppl.e18550
Autor:
Ana I. Velazquez Manana, Dame Idossa, Kelly Jasmin Meza, Juan J. Rodriguez Vargas, Narjust Duma
Publikováno v:
Journal of Clinical Oncology. 40:e18602-e18602
e18602 Background: Disparities persist in the recruitment and enrollment of diverse populations to cancer clinical trials (CT). Barriers to CT participation are numerous and include structural inequities that limit access, stringent eligibility crite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f07f16b9c91d745eb8f642d09908293
https://doi.org/10.1200/jco.2022.40.16_suppl.e18602
https://doi.org/10.1200/jco.2022.40.16_suppl.e18602
Publikováno v:
Journal of Clinical Oncology. 40:11041-11041
11041 Background: The internet and social media have become a common source of medical information. Previous analyses have found that YouTube videos disseminate biased cancer related information of low to moderate quality. We analyzed online informat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cf53feeb9a939ce8cbe330ea989981c
https://doi.org/10.1200/jco.2022.40.16_suppl.11041
https://doi.org/10.1200/jco.2022.40.16_suppl.11041
Autor:
Sara Taveras Alam, Devika G. Das, Urshila Durani, John Colton Thompson, Martina Murphy, Ashok Kumbamu, Alfred Ian Lee, Ariela L. Marshall, Lachelle D. Weeks, Robby Reynolds, Ana I. Velazquez Manana, Jori May, Theodore Wun, Marquita Nelson, Ze Zheng, Elizabeth Henry, Anurekha Gollapudi
Publikováno v:
Blood
Introduction: While the COVID-19 pandemic has affected many aspects of clinical care, research, and medical training, its impact on hematology-oncology trainees and professional development has not been described. The American Society of Hematology (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5291f1cd6b8f0ae08d67c6ac1a3481e
http://europepmc.org/articles/PMC8330314
http://europepmc.org/articles/PMC8330314
Publikováno v:
Journal of Clinical Oncology. 39:266-266
266 Background: Oral oncolytics (OO) offer convenient administration and reduce the burden of cancer treatment, while creating particular challenges regarding safety monitoring and adherence. A baseline review of oral oncolytic education (OOE) at our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9fd020b396698685d0442f614294867
https://doi.org/10.1200/jco.2020.39.28_suppl.266
https://doi.org/10.1200/jco.2020.39.28_suppl.266
Autor:
Martina Murphy, Ashok Kumbamu, Urshila Durani, Ana I. Velazquez Manana, Robby Reynolds, Elizabeth Henry, Ariela L. Marshall, Alfred Ian Lee, Devika G. Das
Publikováno v:
Blood
Introduction The COVID-19 pandemic has significantly affected many aspects of healthcare, including medical education and training. Its impact on hematology/oncology (HO) fellowship programs has not yet been characterized. Methods The American Societ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4211d55c9250b0523ccf067de6f19a
https://doi.org/10.1182/blood-2020-141514
https://doi.org/10.1182/blood-2020-141514